MedJ Takes You to WCLC 2025
Alexander Edward Drilon,MD, Memorial Sloan Kettering Cancer Center, USA. An In-Depth Analysis of the ARROS-1 Study, Revealing How Zidesamtinib Overcomes Resistance in ROS1-Positive Lung Cancer, and Sharing Clinical Breakthroughs as well as Future Directions for Next-Generation Inhibitors!